These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A novel chitosan-citric acid crosslinked beta-cyclodextrin nanocarriers for insoluble drug delivery.
    Author: Karpkird T, Manaprasertsak A, Penkitti A, Sinthuvanich C, Singchuwong T, Leepasert T.
    Journal: Carbohydr Res; 2020 Dec; 498():108184. PubMed ID: 33189031.
    Abstract:
    In this work a new system nanocarrier consisting of chitosan (CS) and beta-cyclodextrin crosslinked citric acid (pbCD) was prepared. Curcumin (cur), which is well-known for having a wide range of biological properties suitable for the treatment of several diseases, was selected as a model for forming the inclusion complex in pbCD and then encapsulated into CS nanoparticles (CSpbCD-cur). The effects of both the concentration of pbCD-cur and the pH were investigated. The CSpbCD-cur nanoparticles were characterised by SEM, FT-IR, DLS, drug loading and in vitro release. The results showed that the size of CSpbCD nanoparticles were unstable at higher pH values (pH ≥ 6) and pbCD concentrations. Moreover, the loading efficiency of the inclusion complex of curcumin with pbCD (pbCD-cur) entrapped into the CS nanoparticles (CSpbCD-cur), increased when the pbCD-cur concentration was increased. The size and size distritution (PDI) of nanoparticles showed the best at the concentration of pbCD-cur 20 mL/mg (with 1.5 mg/mL of CS) at pH 4. The release profile showed that CSpbCD-cur had a slower release than free curcumin resulting in that the cytotoxicity of CSpbCD-cur was less than that of pbCD-cur, and free curcumin, respectively.
    [Abstract] [Full Text] [Related] [New Search]